Ingredient record · Antibiotic (cephalosporin)
Cefixime: bans, restrictions and failed batches in India
Last checked 20 September 2026. Sources: CDSCO banned-drugs notifications and monthly NSQ alerts, Jan 2019 to Jul 2026
13 entries containing Cefixime are on India's banned-drugs list, and 7 are banned today. 91 batches of medicines containing Cefixime failed a government lab test between January 2019 and July 2026, from 69 manufacturers. A failed batch concerns that batch only, not the medicine or every brand.
7
Banned combinations in force
6
Other listed orders (stayed, restricted, quashed)
91
Batches failed a lab test
Jul 2026
Latest lab alert
Is it banned? Our answer pages
Not banned · one combo banned (2024)
On the banned-drugs list
Cefixime on its own is not on CDSCO's banned list. The entries below are specific combinations that contain it. Status follows CDSCO's own notes on each entry.
| Drug / combination | Action | Notification | Date | Order | Status note |
|---|---|---|---|---|---|
| Cefixime 200mg + Ofloxacin 200mg + Lactic Acid Bacillus 60 Million Spores TabletsFixed-dose combination · antibiotics | Halted | CDSCO F.No. 4-01/2023-DC (Misc. 3) dated 11.04.2025, Annexure Sr. 8 | 11 April 2025 | 35 FDCs · Apr 2025 | CDSCO direction to state licensing authorities, 11 Apr 2025, not a Section 26A gazette ban |
| Cefixime 200mg + Azithromycin 250mg + Lactic Acid Bacillus 60 Million Spores Film Coated TabletsFixed-dose combination · antibiotics | Halted | CDSCO F.No. 4-01/2023-DC (Misc. 3) dated 11.04.2025, Annexure Sr. 25 | 11 April 2025 | 35 FDCs · Apr 2025 | CDSCO direction to state licensing authorities, 11 Apr 2025, not a Section 26A gazette ban |
| Cefixime + Acetyl CysteineFixed-dose combination · antibiotics | Banned | S.O. 3413(E) | 2 August 2024 | 156 FDCs · Aug 2024 | Prohibited under s.26A; notifications dated 02.08.2024, gazetted 21-22 Aug 2024. |
| Cefixime + Lactobacillus + Clavulanic AcidFixed-dose combination · antibiotics | Banned | S.O. 214(E) | 11 January 2019 | Other orders | One of 80 FDCs prohibited vide S.O. 180(E)-259(E) dated 11.01.2019 (CDSCO letter 22.01.2019). In force per CDSCO list as on 22.11.2021. |
| Cefixime + OrnidazoleFixed-dose combination · antibiotics | Banned | S.O. 215(E) | 11 January 2019 | Other orders | One of 80 FDCs prohibited vide S.O. 180(E)-259(E) dated 11.01.2019 (CDSCO letter 22.01.2019). In force per CDSCO list as on 22.11.2021. |
| Azithromycin + CefiximeFixed-dose combination · antibiotics | Banned | S.O. 4422(E) | 7 September 2018 | 328 FDCs · Sep 2018 | In force per CDSCO list as on 22.11.2021 |
| Cefixime + LinezolidFixed-dose combination · antibiotics | Banned | S.O. 4425(E) | 7 September 2018 | 328 FDCs · Sep 2018 | In force per CDSCO list as on 22.11.2021 |
| Amoxicillin + Cefixime + Potassium Clavulanic AcidFixed-dose combination · antibiotics | Banned | S.O. 4426(E) | 7 September 2018 | 328 FDCs · Sep 2018 | In force per CDSCO list as on 22.11.2021 |
| Cefixime + LevofloxacinFixed-dose combination · antibiotics | Banned | S.O. 4435(E) | 7 September 2018 | 328 FDCs · Sep 2018 | In force per CDSCO list as on 22.11.2021 |
| Azithromycin + CefiximeFixed-dose combination · antibiotics | Quashed | S.O. 752(E) | 10 March 2016 | 344 FDCs · Mar 2016 | Quashed by Delhi HC 1 Dec 2016; see 2018 re-ban |
| Cefixime + LinezolidFixed-dose combination · antibiotics | Quashed | S.O. 756(E) | 10 March 2016 | 344 FDCs · Mar 2016 | Quashed by Delhi HC 1 Dec 2016; see 2018 re-ban |
| Amoxicillin + Cefixime + Potassium Clavulanic AcidFixed-dose combination · antibiotics | Quashed | S.O. 757(E) | 10 March 2016 | 344 FDCs · Mar 2016 | Quashed by Delhi HC 1 Dec 2016; see 2018 re-ban |
| Cefixime + LevofloxacinFixed-dose combination · antibiotics | Quashed | S.O. 766(E) | 10 March 2016 | 344 FDCs · Mar 2016 | Quashed by Delhi HC 1 Dec 2016; see 2018 re-ban |
Products that failed lab tests
Product names as printed by the testing labs, grouped. Open a product to see every batch number.
| Product | Batches | Makers | Latest |
|---|---|---|---|
| Cefixime | 39 | 34 | Jul 2026 |
| Cefixime Ofloxacin | 12 | 9 | Jul 2026 |
| Cefixime Lactic Acid Bacillus | 9 | 9 | Jul 2026 |
| Cefixime Azithromycin Lactic Acid Bacillus | 8 | 8 | Jul 2026 |
| Cefixime Trihydrate Lactic Acid Bacillus | 3 | 3 | Aug 2025 |
| Cefixime Potassium Clavulanate | 2 | 2 | Apr 2026 |
| Cefixime Dry | 2 | 1 | Mar 2026 |
| Cefixime Azithromycin | 1 | 1 | Jul 2026 |
| Cefixime Ofloxacine Lactic Acid Bacillus | 1 | 1 | Jul 2026 |
| Cefixime Lactic Acid Bacillus Medisefix Lb | 1 | 1 | Dec 2025 |
| Cefixime Lactic Acid Bacillus Cefizoc Lb | 1 | 1 | Jan 2025 |
| Jikcef Lb Cefixime Lactic Acid Bacillus | 1 | 1 | Dec 2024 |
| Jikcf Az Cefixime Azitromycin | 1 | 1 | Dec 2024 |
| Cefem Cefixime Lactic Acid Bacillus | 1 | 1 | Oct 2024 |
| Cefixime Trihydrate Lactic Acid Bacillus Lp Presef Lb Serial No of Nsq Alert April | 1 | 1 | Apr 2024 |
| Cefixime Ofloxacin Lactic Acid Bacillus | 1 | 1 | Apr 2023 |
| Taxim O | 1 | 1 | Feb 2023 |
| Cifazime Az | 1 | 1 | Dec 2022 |
| Secef Cv | 1 | 1 | Sep 2022 |
| Cefiximetablets | 1 | 1 | Sep 2020 |
| Jfix Lb | 1 | 1 | Mar 2020 |
| Cefixime Geceff | 1 | 1 | Jun 2019 |
| Cefixime Micra | 1 | 1 | Jun 2019 |
Most recent failed batches
| Product | Batch | Manufacturer | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|---|
| Cefixime, Ofloxacine & Lactic Acid Bacillus Tablets | ST-25190Mfg 2026-01 · Exp 2027-12 | Candimed Life SciencesUttarakhand | Identity test negative for Cefixime & OfloxacinOther | Lucknow LabState lab | Jul 2026 |
| Cefixime, Azithromycin and Lactic Acid Bacillus Tablets | TB25115Mfg 2025-03 · Exp 2027-02 | Forgo Pharmaceuticals (P) LtdHaryana | Content of anhydrous AzithromycinOther | GORAKHPUR LAB, UPState lab | Jul 2026 |
| Cefixime, Azithromycin & Lactic Acid Bacillus Tablets | ST-25193Mfg 2025-01 · Exp 2027-12 | Candimed Life SciencesUttarakhand | Identity test negative for Cefixime & AzithromycinOther | Lucknow LabState lab | Jul 2026 |
| Cefixime, Azithromycin & Lactic Acid Bacillus Tablets | PL-26089Mfg 2025-09 · Exp 2027-08 | Velnex Medicare India Pvt. Ltd | Identity test negative for Cefixime & AzithromycinOther | Lucknow LabState lab | Jul 2026 |
| Cefixime with Lactic Acid Bacillus Dispersible Tablets | CT/25/792Mfg 2026-01 · Exp 2027-12 | Ciphem PharmaGujarat | The sample does not conform to the claim with respect to Assay of Cefixime Trihydrate Eq. to Anhydrous Cefixime.Assay | DTL JaipurState lab | Jul 2026 |
| Cefixime Tablets IP | 25460922Mfg 2025-05 · Exp 2027-04 | Alkem Health Sciences A Unit of Alkem Laboratories Ltd. Unit-2Sikkim | Identification - Doesn't conforms to I.P.Identification | Lucknow LabState lab | Jul 2026 |
| Cefixime Dispersible Tablets IP 200mg | 25D-BT150Mfg 2025-07 · Exp 2027-06 | Orison Pharma InternationalHimachal Pradesh | The Sample does not Comply for Description as the Tablets shows Light Brown coloured Spots all over the Surface of the Tablets.Description | FDAL, Chhatrapati SambhajinagarState lab | Jul 2026 |
| Cefixime Dispersible Tablets IP | DB240368Mfg 2024-12 · Exp 2026-11 | Daxin Pharmaceuticals Pvt. LtdHimachal Pradesh | The sample does not conform to I.P. w.r.to the tests for AssayAssay | SDTL,GuwahatiState lab | Jul 2026 |
| Cefixime Dispersible Tablets I.P. | CCT-24035Mfg 2024-07 · Exp 2026-06 | Catrax Healthcare Pvt. LtdHimachal Pradesh | 01. ASSAY OF CEFIXIME TRIHYDRATE I.P. ?Less than prescribed limit.Assay | SFDTL UttarakhandState lab | Jul 2026 |
| Cefixime & Ofloxacin Dispersible Tablets | T4646Mfg 2024-11 · Exp 2027-04 | Titanes Pharma | The sample does not conform to the claim with respect to Assay, Uniformity of dispersion and Disintegration.Assay | DTL JaipurState lab | Jul 2026 |
| Cefixime & Lactic Acid Bacillus Tablets | DF-8021Mfg 2026-03 · Exp 2028-02 | Velnex Medicare India Pvt. Ltd | Identity test negative for CefiximeOther | Lucknow LabState lab | Jul 2026 |
| Cefixime & Azithromycin Tablets | MWDC-5421GMfg 2026-01 · Exp 2027-12 | Geenac PharmaUttarakhand | Identity test negative for Cefixime & AzithromycinOther | Lucknow LabState lab | Jul 2026 |
| Cefixime Dispersible Tablet IP | VT240492Mfg 2024-05 · Exp 2026-04 | VADSP PharmaceuticalsHimachal Pradesh | The sample does not conform to the IP with respect to Assay of Cefixime Trihydrate eq. to Anhydrous Cefixime.Assay | DTL BikanerState lab | Jun 2026 |
| Cefixime Dispersible Tablets IP 200 mg | AB24069Mfg 2024-11 · Exp 2026-10 | Skymap Pharmaceuticals Pvt. LtdUttarakhand | MisbrandedMisbranded | SDTL, UttarakhandState lab | May 2026 |
| Cefixime Tablets IP 200 mg | 25460922Mfg 2025-05 · Exp 2027-04 | Alkem Health ScienceSikkim | The sample does not conform to I.P. w.r.to the tests for Identification and Assay SpuriousAssay | SDTL, AssamState lab | Apr 2026 |
Showing 15 of 91 records
Holding a strip or bottle? The batch number is printed after "B. No." Check it against every alert. If it matches, return it to the pharmacy. What the labels mean: status guide.